¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"first pass study"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® cohort study ÇÑ±Û °èȹ¿¬±¸, ÀüÇ⿬±¸, ¾Õ¹æÇ⿬±¸
¼³¸í   
  ºÐ¼®¿ªÇп¡¼­ÀÇ ¿äÀÎ-´ëÁ¶¿¬±¸ÀÇ ÇÑ ±â¹ýÀÌ´Ù. »ç¶÷ÀÇ Áý´Ü¿¡¼­ Áúº´À¯Çà°ú °¡¼³¿äÀΰúÀÇ ¿¬°ü¼ºÀ» °íÂûÇÏ¿© Àΰú°ü°è¸¦ ¹àÈ÷´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. °¡¼³¿äÀÎÀ» °®´Â Áý´Ü°ú °®Áö ¾Ê´Â Áý´Ü, È¤Àº ÀûÀº Áý´Ü°ú ¸¹Àº Áý´ÜÀÇ 2±º(ÄÚȣƮ)À¸·Î ³ª´©¾î ÃßÀû Á¶»çÇÏ¿© °¢ Áý´Ü¿¡¼­ÀÇ Áúº´ÀÇ ¹ß»ýºóµµ¸¦ ºñ±³Çϴ °ÍÀÌ´Ù. ÀϹÝÀûÀ¸·Î´Â ÀüÇâÀûÀΠ¿¬±¸·Î ÇàÇØÁö´Â °æ¿ì°¡ ¸¹À¸³ª ÈÄÇâÀûÀΠ¿¬±¸·Îµµ ÇàÇÏ¿©Áø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first-pass metabolism
    óÀ½Åë°ú´ë»ç
  • high-pass filter
    °íÁÖÆÄÅë°ú¿©°ú±â, °íÁÖÆÄÅë°ú°Å¸£°³
  • low-pass filter
    ÀúÁÖÆÄÅë°ú¿©°ú±â, ÀúÁÖÆÄÅë°ú°Å¸£°³
  • single pass technique
    ÀÏȸÅë°ú±â¹ý, ´ÜÀÏÅë°ú±â¹ý
  • first aid
    ÀÏÂ÷ÀÀ±Þóġ, ÀÏÂ÷±¸±Þ
  • first filial generation
    ÀÏ´ëÀâÁ¾, ÀâÁ¾Á¦Àϼ¼´ë
  • first heart sound
    Á¦1½É(Àå)À½
  • first responder
    ÀÏÂ÷¹ÝÀÀÀÚ
  • first-degree burn
    ÀϵµÈ­»ó
  • first-order neuron
    ÀÏÂ÷½Å°æ¼¼Æ÷, ÀÏÂ÷½Å°æ¿ø
  • first-set reaction
    ÀÏÂ÷°ÅºÎ¹ÝÀÀ
  • first-set rejection
    ÀÏÂ÷°ÅºÎ¹ÝÀÀ
  • air study
    °ø±âÁÖÀÔ°Ë»ç
  • cohort study
    ÄÚȣƮ¿¬±¸, ÄÚȣƮÁ¶»ç
  • controlled clinical study
    °ü¸®È­ÀÓ»ó½ÃÇè
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • study design
    ¿¬±¸¼³°è
  • study
    ¿¬±¸, °Ë»ç, Á¶»ç
  • arterial blood gas study
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • case-control study
    ȯÀÚ´ëÁ¶±º¿¬±¸
  • cohort study
    ÄÚȣƮ¿¬±¸
  • cross-sectional study
    ´Ü¸éÁ¶»ç¿¬±¸
  • ecological study
    »ýÅ¿¬±¸
  • longitudinal study
    ÃßÀû¿¬±¸
  • observational study
    °üÂû¿¬±¸
  • pilot study
    ¿¹ºñ¿¬±¸
  • population study
    Àα¸Á¶»ç
  • prospective study
    ÀüÇ⿬±¸, °èȹ¿¬±¸, ¾Õ¹æÇ⿬±¸, Àü¸Á¿¬±¸
  • prospective cohort study
    ÀüÇâÄÚȣƮ¿¬±¸
  • retrospective study
    ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸, ȸ°í¿¬±¸
  • retrospective cohort study
    ÈÄÇâÄÚȣƮ¿¬±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first pass study
    ÀÏÂ÷Åë°ú°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high-pass filter
    °íÁÖÆÄÅë°ú°Å¸£°³, °íÁÖÆÄÅë°úÇÊÅÍ
  • low-pass filter
    ÀúÅë°ú°Å¸£°³, ÀúÅë°ú¿©°ú±â
  • single pass technique
    ÀÏȸÅë°ú±â¹ý, ´ÜÀÏÅë°ú±â¹ý
  • first aid
    ±¸±Þ, ÀÀ±Þóġ
  • first stage
    Á¦Àϱâ
  • first filial generation
    ÀÏ´ëÀâÁ¾, ÀâÁ¾Á¦Àϼ¼´ë
  • first set reaction
    ÀÏÂ÷°ÅºÎ¹ÝÀÀ
  • first-order neuron
    ÀÏÂ÷½Å°æ¼¼Æ÷
  • first-rank symptom
    ÀϱÞÁõ»ó
  • first-set rejection
    ÀÏÂ÷°ÅºÎ
  • air study
    °ø±âÁÖÀÔ°Ë»ç
  • arterial blood gas study
    µ¿¸ÆÇ÷°¡½ººÐ¼®
  • cardiac gated MR study
    ½ÉÀ嵿±âÀÚ±â°ø¸í°Ë»ç
  • case study
    Áõ·Ê¿¬±¸
  • case comparison study
    ȯÀÚ´ëÁ¶±º¿¬±¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hepatic first pass effect
    °£ÃÊȸÅë°úÈ¿°ú.
  • Ficks first law
    ÇÈÁ¦ÀϹýÄ¢(ÛööÎ).
  • First heart sound
    Á¦1½ÉÀ½(ãýëå)
  • First pain
    ÀÏÂ÷Åë(ìéó­÷Ô)
  • First-degree atrioventricular block
    1µµ(Óø) ¹æ½ÇÂ÷´Ü(Û¨ãøó´Ó¨)
  • B cell study
    B ¼¼Æ÷°Ë»ç
  • air study
    °ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
  • arterial blood gas study
    µ¿¸ÆÇ÷ °¡½ººÐ¼®
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • phase 1 study
    ÀÓ»óÁ¦1»ó½ÃÇè.
  • pilot study
    ¿¹ºñ½ÇÇè.
  • population study
    Àα¸Á¶»ç
  • preclinical study
    ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
  • pressure flow study
    ¾Ð·ù·® Á¶»ç
  • pressure-perfusion study
    ¾Ð·Â°ü·ù°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first pass study
    ÀÏÂ÷Åë°ú°Ë»ç.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first pass effect
    ÀÏÂ÷Åë°úÈ¿°ú.
  • first-pass MR imaging
    ÀÏÂ÷ Åë°ú ÀÚ±â°ø¸í¿µ»ó
  • hepatic first pass effect
    °£ÃÊȸÅë°úÈ¿°ú.
  • low pass filter
    ÀúÅë°ú ¿©°ú±â
  • single pass technique
    1ȸ Åë°ú ±â¹ý (ìéüÞ ÷×Φ ÐüÛö)
  • single pass technique
    ´ÜÀÏ Åë°ú ±â¹ý
  • air study
    °ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
  • arterial blood gas study
    µ¿¸ÆÇ÷ °¡½ººÐ¼®
  • cardiac gated MR study
    ½ÉÀ嵿±â ÀÚ±â°ø¸í °Ë»ç
  • case control study
    ȯÀÚ´ëÁ¶¿¬±¸.
  • case study
    Áõ·Ê¿¬±¸(Áõ¿¹¿¬±¸).
  • case study
    Áõ·Ê¿¬±¸(ñøçÓæÚϼ).
  • cohort study
    ÄÚ¿ÀÆ®¿¬±¸(ÊÙËçË´), Æø·ÎºñÆø·Î¿¬±¸.
  • controlled clinical study
    (Ãß°èÇÐÀû) °ü¸®È­(Ì§Ë­Ì°ËøË´ËöÌ´)(ÀÓ»ó)½ÃÇè( ËöË×ËàÌ´).
  • double-blind study
    ÀÌÁ߸ͰË.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Atlas [First cervical vertebra]
    °í¸®»À [ȯÃß°ñ]
    [¿¾ ¿ë¾î] ȯÃß(Á¦1°æÃß)
  • Coccyx [First-fourth coccygeal vertebrae]
    ²¿¸®»À [ù°-³Ý°²¿¸®(ôÃß)»À] [¹Ì°ñ]
    [¿¾ ¿ë¾î] ¹Ì°ñ
  • Thoracic vertebrae(first-twelfth)
    µî(ôÃß)»À(ù°-¿­µÎ°) [ÈäÃß°ñ]
    [¿¾ ¿ë¾î] ÈäÃß°ñ
  • Cervical vertebrae(first-seventh)
    ¸ñ(ôÃß)»À(ù°-Àϰö°) [°æÃß°ñ]
    [¿¾ ¿ë¾î] °æÃß
  • Metatarsal bones(First-fifth)
    ¹ßÇ㸮»À(ù°-´Ù¼¸Â°)
    [¿¾ ¿ë¾î] ÁßÁ·(ô)°ñ(Á¦1-Á¦5)
  • Metacarpal bones(first-fifth)
    ¼ÕÇ㸮»À(ù°-´Ù¼¸Â°)
    [¿¾ ¿ë¾î] Áß¼ö(Àå)°ñ
  • Great[First] toe
    ¾öÁö¹ß°¡¶ô
    [¿¾ ¿ë¾î] ¹«Áö
  • Sacrum [First-fifth sacral vertebrae]
    ¾ûÄ¡»À [ù°-´Ù¼¸Â°¾ûÄ¡(ôÃß)»À] [õ°ñ]
    [¿¾ ¿ë¾î] õ°ñ
  • First polar body
    ÀÏÂ÷±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • First arch
    ù°±ÁÀÌ
    [¿¾ ¿ë¾î] Á¦ÀϱÃ
  • First polar body
    ù°±ØÃ¼
    [¿¾ ¿ë¾î] ÀÏÂ÷±ØÃ¼
  • First aortic arch
    ù°´ëµ¿¸ÆÈ°
    [¿¾ ¿ë¾î] Á¦Àϴ뵿¸Æ±Ã
  • First posterior intercostal artery
    ù°µÚ°¥ºñ»çÀ̵¿¸Æ
    [¿¾ ¿ë¾î] Á¦1´Á°£µ¿¸Æ
  • Tuberosity of first metatarsal bone
    ù°¹ßÇ㸮»À°ÅÄ£¸é
    [¿¾ ¿ë¾î] Àç1ÁßÁ·(ô)°ñÁ¶¸é
  • First sternocostal synchondrosis
    ù°º¹Àå°¥ºñÀ¯¸®¿¬°ñ°áÇÕ
    [¿¾ ¿ë¾î] Á¦1È两¿¬°ñ°áÇÕ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first intermediate host
    Á¦ÀÏÁß°£¼÷ÁÖ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blance study
    ±ÕÇü¿¬±¸(гû¬æÚϼ)
  • error of the first kind
    Á¦ 1 Á¾ ¿ÀÂ÷(è¦ó¬)
  • Fick's first law
    ÇÈ Á¦ 1 ¹ýÄ¢(ÛööÎ)
  • first law of thermodynamics
    ¿­¿ªÇÐ(æðÕôùÊ) Á¦ 1 ¹ýÄ¢(ÛööÎ)
  • first messenger
    "ÀÏÂ÷ Àü·É (ìéó­ îîÖµ), ù° Àü·É (îîÖµ)"
  • first-order kinetics
    ÀÏÂ÷ ¿ªµ¿ÇÐ (ìéó­ æ³ÔÑùÊ)
  • first-order reaction
    ÀÏÂ÷ ¹ÝÀÀ (ìéó­ Úãëë)
  • pseudo-first-order kinetics
    À§ÀÏÂ÷¿ªÇÐ(êÊìéó­ÕôùÊ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • first-pass MR imaging
    ÀÏÂ÷Åë°úÀÚ±â°ø¸í¿µ»ó
  • first aid
    ±¸±Þ, ÀÀ±Þóġ
  • low pass filter
    ÀúÅë°ú¿©°ú±â
  • single pass technique
    ´ÜÀÏÅë°ú±â¹ý
  • air study
    °ø±â(ÁÖÀÔ)°Ë»ç(¹ý)
  • cardiac gated MR study
    ½ÉÀ嵿±âÀÚ±â°ø¸í°Ë»ç
  • pilot study
    ¿¹ºñ½ÇÇè
  • prospective study
    ÀüÇâÀû¿¬±¸
  • real time study
    ½Ç½Ã°£°Ë»ç
  • retrospective study
    ÈÄÇ⼺¿¬±¸
  • study of choice
    ÃÖ¼±ÀÇ °Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
C1 first cervical nerve; first cervical vertebra; first component of complement
FPRA first pass radionuclide angiogram
FIFO first in, first out
HPF heparin-precipitable fraction; hepatic plasma flow; high-pass filter; high-power field [microscope];...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FP First pass
FPM First pass metabolism
FPRNA First-pass radionuclide angiography
CABG Coronary artery by-pass surgery
HRP High-Pass Resolution Perimetry
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • first pass effect
    ÀÏÂ÷ Åë°ú È¿°ú
  • first aid
    ±¸±Þ, ÀÀ±Þ óġ
  • first bicuspid
    Á¦ ÀÏ ¼Ò±¸Ä¡
  • first branchial arch
    Á¦ 1 ÀεαÃ
  • first cervical vertebra
    ȯÃß, Á¦ 1°æÃß
    µ¿ÀǾî=atlas.
  • first degree
    1µµ
  • first degree relative
    ÀϵîÄ£
  • first intention
    ÀÏÂ÷¼º À¯Âø
    ¿Ü»óÀÌ À°¾ÆÁ¾À» ¹ß»ýÇÏÁö ¾Ê°í Á÷Á¢ À¯ÂøÇÏ´Â °Í.
  • first molar
    Á¦ Àϴ뱸ġ
    µ¿ÀǾî=
  • first order reaction
    ÀÏÂ÷ ¹ÝÀÀ
    ¹ÝÀÀ ¼Óµµ°¡ ¹ÝÀÀ¿¡ °ü¿©ÇÏ´Â ¹°Áú Áß ¾î´À ÇϳªÀÇ ³óµµ¿¡ ºñ·ÊÇÏ´Â ¹ÝÀÀ.
  • first set rejection
    ÀÏÂ÷ °ÅºÎ, ÀÏÂ÷ °ÅºÎ ¹ÝÀÀ
    Á¦ 1ȸ°ÀÇ µ¿Á¾ À̽Ŀ¡ ÀϾ´Â °ÅºÎ ¹ÝÀÀÀÇ ¾ç½ÄÀÌ¸ç ºÎÀûÇÕÀÇ Á¤µµ¿¡ µû¶ó 1-3ÁÖ°£ÀÇ Àẹ±â¸¦ °ÅÃÄ ÀÌ½Ä ÆíÀº Å»¶ôÇÑ´Ù. ÀÌ½Ä °ÅºÎ ¹ÝÀÀµµ ºñÀÚ±âÀÇ Ç׿ø¼ºÀ» °¡Áø ¼¼Æ÷¸¦ Á¦°ÅÇϱâ À§ÇÑ ¸é¿ª ¹ÝÀÀÀÌ´Ù.
  • first stage dental implant surgery
    ÀÏÂ÷ Ä¡°ú ÀÓÇöõÆ® ¼ö¼ú
  • first-rank symptom
    ÀÏ±Þ Áõ»ó
  • first-time dental patient
    óÀ½ ³»¿øÇÑ È¯ÀÚ
  • lower first bicuapid
    ÇÏ¾Ç Á¦ 1¼Ò±¸Ä¡
    Á¤Áß¼±¿¡¼­ 4¹øÂ° Ä¡¾Æ·Î °ßÄ¡¿Í Á¦2¼Ò±¸Ä¡ »çÀÌ¿¡ À§Ä¡ÇÏ¸ç ¼Ò±¸Ä¡ Áß °¡Àå ÀÛÀº Ä¡¾ÆÀÌ¸ç ¼³Ãø ±³µÎÀÇ ¹ßÀ°ÀÌ ¸Å¿ì ¾àÇÏ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ventriculography, first-pass Radionuclide ventriculography where a bolus of radionuclide is injected and data are recorded from one pass through the heart ventricle. Left and right ventricular function can be analyzed independently during this technique. First-pass ventriculography is preferred over gated blood pool imaging for assessing right ventricular function.
(12 Dec 1998)
pass 1. An opening, road, or track, available for passing; especially, one through or over some dangerous or otherwise impracticable barrier; a passageway; a defile; a ford; as, a mountain pass. ""Try not the pass!" the old man said." (Longfellow)
2. A thrust or push; an attempt to stab or strike an adversary.
3. A movement of the hand over or along anything; the manipulation of a mesmerist.
4. A single passage of a bar, rail, sheet, etc, between the rolls.
5. State of things; condition; predicament. "Have his daughters brought him to this pass." (Shak) "Matters have been brought to this pass." (South)
6. Permission or license to pass, or to go and come; a psssport; a ticket permitting free transit or admission; as, a railroad or theater pass; a military pass. "A ship sailing under the flag and pass of an enemy." (Kent)
7. A thrust; a sally of wit.
8. Estimation; character. "Common speech gives him a worthy pass." (Shak)
9. [Cf. Passus] A part; a division. Pass boat, a wooden or metallic box, used to carry cartridges from the service magazine to the piece. Pass check, a ticket of admission to a place of entertainment, or of readmission for one who goes away in expectation of returning.
Origin: Cf. F. Pas (for sense 1), and passe, fr. Passer to pass. See Pass.
Source: Websters Dictionary
(01 Mar 1998)
high-pass filter A device or material that allows high frequency signals to pass while attenuating other signals.
(05 Mar 2000)
low-pass filter A device or material with the opposite effect from a high-pass filter; most tissues act as low-pass filters of ultrasound signals.
(05 Mar 2000)
analytic study In epidemiology, a study designed to examine associations, commonly putative or hypothesised causal relationships; usually concerned with identifying or measuring the effects of risk factors or with the health effects of specific exposures.
(05 Mar 2000)
blinded study Clinical trials of drugs are often done blinded so that the patient does not know (is blinded as to) whether they are receiving the product being tested or the control/placebo to ensure that the results of a study are not affected by a possible placebo effect (by the power of suggestion).
(12 Dec 1998)
blind study A study in which the experimenter is unaware of which group is subject to which procedure.
(05 Mar 2000)
case-control study <epidemiology> A study in which the risk factors of people with a disease are compared with those without a disease.
It is an epidemiological method that begins by identifying persons with the disease or condition of interest (the cases) and compares their past history of exposure to identified or suspected risk factors with the past history of similar exposures among persons who resemble the cases but do not have the disease or condition of interest (the controls).
The relationship of an attribute to the disease can therefore be examined by comparing affected and non-affected individuals with regard to the frequency or levels of the attribute in each group.
(05 May 2002)
retrospective study <epidemiology> A study in which people are enrolled and then have their history of risks, infections or disease measured.
(05 Dec 1998)
rosenzweig picture-frustration study A projective test depicting cartoon-like characters in frustrating situations. The scoring of the subject's responses indicates the direction of hostility or aggression, that is, whether he blames himself, the other person, or the set of circumstances.
(12 Dec 1998)
cohort study A study using epidemiological methods, such as a clinical trial, in which a cohort with a particular attribute (e.g., smokers, recipients of a drug) is followed prospectively and compared for some outcome (e.g., disease, cure) with another cohort not possessing the attribute.
(05 Mar 2000)
pioped study <radiology> 251 patients with documented PE on pulmonary angiograms were given V/Q scans: 102 high probability, 105 intermediate probability, 39 low probability, 5 normal or near-normal
(12 Dec 1998)
multicenter study A controlled study executed by several cooperating institutions.
(12 Dec 1998)
multigeneration study Toxicity test in which at least 3 generations of the test organisms are exposed to the substance being assessed. Exposure is usually continuous.
Any medical study which follows a family of people through several generations.
(09 Oct 1997)
crossover study <statistics> A study that compares two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. Usually refers to a study in which the subject is switched from the experimental to the control procedure (or vice versa).
In the case of two treatments, a and b, half the subjects are randomly allocated to receive these in the order a, b and half to receive them in the order b, a.
A criticism of this design is that effects of the first treatment may carry over into the period when the second is given.
With this type of study, every patient serves as his or her own control.
(21 Jun 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • study
    °øºÎ,¼­Àç,Çаú,¹è¿ì´Ù,¿¬±¸ÇÏ´Ù
  • brown study
    ¸ÛÇÏ´Ï»ý°¢¿¡Àá±è
  • case study
    »ç·Ê¿¬±¸;ÄÉÀ̽º ½ºÅ͵ð M
  • desk study
    (¿µ)Ź»ó ¿¬±¸
  • feasibility study
    Ÿ´ç¼º Á¶»ç;¿¹ºñ Á¶»ç
  • field study
    =FIELDWORK
  • home study
    (Åë½Å ±³À°¿¡¼­ÀÇ)ÀÚÅà ÇнÀ;(¹Ì)(¾çºÎ¸ð·Î¼­ÀÇ ÀûºÎ¸¦ ¾Ë¾Æº¸´Â)°¡Á¤Á¶»ç
  • home study
    Åë½Å±³À°
  • nature study
    ÀÚ¿¬°øºÎ(²É »õ ±¤¼® ³¯¾¾µîÀÇ °üÂû,±¹¹ÎÇб³ÀÇ Çаú ''
  • study
    ½ÀÀÛ;½ÃÀÛ;¼­Àç;¿¬±¸½Ç;¾Ö¾¸
  • study
    ÇÏ´Ù;¾Ö¾²´Ù;(¹Ì)¼÷°íÇÏ´Ù
  • study
    ÇÏ´Ù;(´ë»çµîÀ»)¾Ï±âÇÏ´Ù
  • by-pass
    ¿ìȸ·Î
  • pass
    ÅëÇÏ´Ù,ÇÕ°ÝÇÏ´Ù,Áö³ª°¡´Ù,°ú°Å
  • pass for
    -À¸·Î ÅëÇÏ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á